249 related articles for article (PubMed ID: 30320343)
21. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR.
Ma HP; Kong WX; Li XY; Li W; Zhang Y; Wu Y
Oncol Rep; 2019 Mar; 41(3):1549-1559. PubMed ID: 30747217
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
23. CLDN1 Increases Drug Resistance of Non-Small Cell Lung Cancer by Activating Autophagy via Up-Regulation of ULK1 Phosphorylation.
Zhao Z; Li J; Jiang Y; Xu W; Li X; Jing W
Med Sci Monit; 2017 Jun; 23():2906-2916. PubMed ID: 28614291
[TBL] [Abstract][Full Text] [Related]
24. SIRT3 is correlated with the malignancy of non-small cell lung cancer.
Xiong Y; Wang M; Zhao J; Wang L; Li X; Zhang Z; Jia L; Han Y
Int J Oncol; 2017 Mar; 50(3):903-910. PubMed ID: 28197634
[TBL] [Abstract][Full Text] [Related]
25. Expression of HAb18G in non-small lung cancer and characterization of activation, migration, proliferation, and apoptosis in A549 cells following siRNA-induced downregulation of HAb18G.
Xu X; Liu S; Lei B; Li W; Lin N; Sheng W; Huang A; Shen H
Mol Cell Biochem; 2013 Nov; 383(1-2):1-11. PubMed ID: 24013786
[TBL] [Abstract][Full Text] [Related]
26. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
[TBL] [Abstract][Full Text] [Related]
27. HES5 promotes cellular proliferation of non-small cell lung cancer through STAT3 signaling.
Gu S; Zhang R; Gu J; Li X; Lv L; Jiang J; Xu Z; Wang S; Shi C; Wang DP; Wu C
Oncol Rep; 2017 Jan; 37(1):474-482. PubMed ID: 27878283
[TBL] [Abstract][Full Text] [Related]
28. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
29. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
[TBL] [Abstract][Full Text] [Related]
30. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
Zhu X; Guo X; Wu S; Wei L
Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
[TBL] [Abstract][Full Text] [Related]
31. HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer.
Shao H; Gu Y; Ding J; Lu P; Ruan T; Lu W
Tumour Biol; 2016 Feb; 37(2):2621-7. PubMed ID: 26392113
[TBL] [Abstract][Full Text] [Related]
32. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
33. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
[TBL] [Abstract][Full Text] [Related]
34. PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer.
Liu T; Yin H
Oncol Rep; 2017 Jan; 37(1):193-200. PubMed ID: 27878287
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of TM7SF4 inhibits cell proliferation and metastasis of A549 cells through regulating the PI3K/AKT/mTOR signaling pathway.
Yang X; Song X; Wang X; Liu X; Peng Z
Mol Med Rep; 2017 Nov; 16(5):6122-6127. PubMed ID: 28849122
[TBL] [Abstract][Full Text] [Related]
36. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Gremlin promotes non-small cell lung cancer progression.
Yin Y; Yang Y; Yang L; Yang Y; Li C; Liu X; Qu Y
Tumour Biol; 2016 Feb; 37(2):2597-602. PubMed ID: 26392110
[TBL] [Abstract][Full Text] [Related]
38. Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cells.
Xu H; Gao H; Li H; Li D; Yuan W; Zhang L; Cheng P; Su X; Li Z; Wang G; Zhang T
Mol Med Rep; 2020 Oct; 22(4):2966-2972. PubMed ID: 32945387
[TBL] [Abstract][Full Text] [Related]
39. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
[TBL] [Abstract][Full Text] [Related]
40. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
